Export this record

Export record to excel

File type to download

Beta version

Select record 1

ArticlesPeer ReviewedFull Text

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

Author / Creator:Monk, Bradley J, Prof ; Poveda, Andrés, MD ; Vergote, Ignace, MD ; Raspagliesi, Francesco, MD ; Fujiwara, Keiichi, MD ; Bae, Duk-Soo, MD ; Oaknin, Ana, MD ; Ray-Coquard, Isabelle, MD ; Provencher, Diane M, MD ; Karlan, Beth Y, MD ; Lhommé, Catherine, MD ; Richardson, Gary, MD ; Rincón, Dolores Gallardo, MD ; Coleman, Robert L, MD ; Herzog, Thomas J, MD ; Marth, Christian, PhD ; Brize, Arija, MD ; Fabbro, Michel, MD ; Redondo, Andrés, MD ; Bamias, Aristotelis, PhD ; Tassoudji, Marjan, MS ; Navale, Lynn, MS ; Warner, Douglas J, MD ; Oza, Amit M, MD

Publisher:England: Elsevier Ltd

Journal title:The lancet oncology, 2014-07, Vol.15 (8), p.799-808

View online as a Library member

Export record to excel

Export this record

Export record to excel

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

Refine your search